Sure, investors need to evaluate Nepstar's financials, but it doesn't take a seasoned analyst to spot the growth potential this company holds, driven by a potentially explosive Chinese economy and that country's consumers shifting from small shops to larger drug stores. Although many were surprised at first, a second look shows how Nepstar was able to issue such a large dividend this year. This trend shows no reason to stop in the near term.
Rating: Strong Buy.
$7.41 (11/09/09)
